Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Adjusting your budget mid month can be simple. Explore these quick tips to make the process easier.
22,217 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Bitcoin steadies above $70,000 amid regional tensions, as analysts argue geopolitics fail break bitcoin could spark a...
Wednesday brought an outsized move for Sprinklr as earnings beat and optimism around CXM services spurred fresh buyin...
Mission Produce enters 2026 with a mix of hedges, growing demand, and a tight supply chain. This guide breaks down wh...
Biotech stocks rally as late-stage trial data and regulatory milestones boost investor confidence. Analysts say the b...
Bitcoin surged past $74,000 as institutional buying returned to the market, sparking a wider crypto rally. Investors ...
Bitcoin sits near a critical level around $73,500 ahead of the March FOMC decision, with investors parsing policy sig...
Bill Ackman is pursuing a Berkshire Hathaway–style Pershing Square, with Amazon and Meta as core bets. The strategy h...
Delta Air Lines posted a notable weekly gain, with delta stock 9.38% this week, even as retail social chatter turned ...
Swarmer’s 520% debut gain transformed a modest-revenue drone-software company into a market curiosity. With no analys...
Palantir connects data, software, and decision-making in a way that could reshape enterprise AI. This guide outlines ...
Viomi (VIOT) 2025 earnings are shaping up as a pivotal moment for this IoT home player. This guide breaks down what t...